According to Aker BioMarine's latest financial reports the company's current EPS (TTM) is -HK$0.21. In 2023 the company made an earnings per share (EPS) of -HK$0.07629 a decrease over its 2022 EPS that were of HK$0.08731.
Year | EPS | Change |
---|---|---|
2024 (TTM) | -HK$0.22 | 183.12% |
2023 | -HK$0.07629 | -187.38% |
2022 | HK$0.08731 | -210.12% |
2021 | -HK$0.07928 | 24.61% |
2020 | -HK$0.06362 | -78.72% |
2019 | -HK$0.30 | 3258.09% |
2018 | -HK$0.008904 | |
2012 | -HK$6.73 | 26073.64% |
2011 | -HK$0.02573 | -135.79% |
2010 | HK$0.07189 | -109.22% |
2009 | -HK$0.78 | 2.17% |
2008 | -HK$0.76 | 39.37% |
2007 | -HK$0.55 |